ELISA CANDOR

Download

Package inserts

LowCross-Buffer®
Low-Cross-HRP®
Low-Cross® HRP-Stab
HRP-Protector™
AP-Protector®
The Blocking Solution
PlateBlock™
SmartBlock™
BSA-Block
Liquid Plate Sealer®
Washing Buffer 10x
Antibody Stabilizer
Coating Buffer 10x
Stripping Buffer
Sample Buffer
ReadyTector®

Brochures

corporate brochure CANDOR
product brochure CANDOR
ReadyTector®

Reference list

scientific citations

Links

Genetic Engineering & Biotechnology News Jul 1 2008 (Vol. 28, No. 13)
Assay: Avoiding Interference in Immunoassays

Miscellaneous

DIN EN ISO 9001:2015 certificate

Publications

Laborwelt Nr.4/2005-Vol. 6 (translated article) (in English): optimisation of assays: Interference in immunoassays recognize and avoid
Laborwelt Nr. 6/2007 - Vol. 8 (translated article): (in English) long-term stabilization of assay components
IVD Technology March 2009 Volume 15 No. 2 - ASSAY DEVELOPMENT Affinity discrimination to avoid interference in assays
BIOspektrum 04.06, 12. Jahrgang S. 398-400 (translated article): (inEnglish) ELISA validation - The right strategy saves much costs!
Specificity, positive predicted value and validation statistics in the context of CoViD-19
The Covid-19 antibody test challenge
SARS CoV-2 antibody tests, translated article, original published in |transkript 2.2020

- the two biotechnology companies CANDOR Bioscience GmbH and trenzyme GmbH make with their products an important contribution to COVID-19 test development

Konstanz and Wangen, June 22, 2020 – In dealing with the COVID 19 pandemic, a reliable SARS-CoV-2 antibody test is urgently…

This white paper describes how to avoid false-positives in CoViD-19 antibody ELISA testing by using appropriate solutions.

CANDOR Bioscience GmbH
Simoniusstrasse 39
88239 Wangen, Germany

Phone +49 (0) 75 22 - 7952 70
Fax +49 (0) 75 22 - 7952 729
info@candor-bioscience.com